
LFST
LifeStance Health Group Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
4.195
Open
4.190
VWAP
4.14
Vol
1.83M
Mkt Cap
1.61B
Low
4.100
Amount
7.59M
EV/EBITDA(TTM)
34.19
Total Shares
382.29M
EV
1.76B
EV/OCF(TTM)
13.98
P/S(TTM)
1.23
LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 7,400 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
374.50M
+15.05%
--
--
358.37M
+14.6%
--
--
345.08M
+10.49%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for LifeStance Health Group, Inc. (LFST) for FY2025, with the revenue forecasts being adjusted by -0.31% over the past three months. During the same period, the stock price has changed by -36.60%.
Revenue Estimates for FY2025
Revise Downward

-0.31%
In Past 3 Month
Stock Price
Go Down

-36.60%
In Past 3 Month
6 Analyst Rating

110.14% Upside
Wall Street analysts forecast LFST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LFST is 8.70 USD with a low forecast of 8.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
1 Hold
0 Sell
Strong Buy

110.14% Upside
Current: 4.140

Low
8.00
Averages
8.70
High
10.00

110.14% Upside
Current: 4.140

Low
8.00
Averages
8.70
High
10.00
BTIG
Buy
initiated
$8
2025-07-25
New
Reason
BTIG
Price Target
$8
2025-07-25
New
initiated
Buy
Reason
BTIG initiated coverage of LifeStance with a Buy rating and $8 price target. The firm says LifeStance is one of the country's largest outpatient mental health providers. It notes that 90% of the company's patients are commercially insured, making it well networked into health systems and referring hospitals. BTIG believes commercially insured lives are the most attractive segment of the market since insurance rates are typically well above Medicare and Medicaid rates. LifeStance is differentiated given its in-person and virtual care model, the analyst tells investors in a research note.
UBS
Kevin Caliendo
Neutral -> Buy
upgrade
$8.50
2025-05-27
Reason
UBS
Kevin Caliendo
Price Target
$8.50
2025-05-27
upgrade
Neutral -> Buy
Reason
Keybanc
Steve Dechert
Buy
Initiates
$9
2025-04-08
Reason
Keybanc
Steve Dechert
Price Target
$9
2025-04-08
Initiates
Buy
Reason
KeyBanc initiated coverage of LifeStance with an Overweight rating and $9 price target. The firm expects mid-teens organic sales growth over the next couple of years from the company, driven mainly by higher visit volumes on further clinician adds and increasing total revenue per visit on payor reimbursement rate improvement. It also expects margin expansion on the company's recently optimized real estate footprint, clinician productivity, higher margin specialty offerings, and continued cost efficiencies driven by technology enhancements.
Canaccord Genuity
Richard Close
Strong Buy
Initiates
$8
2025-04-03
Reason
Canaccord Genuity
Richard Close
Price Target
$8
2025-04-03
Initiates
Strong Buy
Reason
Canaccord analyst Richard Close initiated coverage of LifeStance with a Buy rating and $8 price target. LifeStance is the largest clinic-based therapy provider, serving its clients both through in-person and virtual visits, the analyst tells investors in a research note. The firm says the company offers the only hybrid, in-person and virtual therapy company to invest in. It believes LifeStance's acquisition strategy offers growth upside.
Goldman Sachs
Jamie Perse
Hold
to
Strong Buy
Upgrades
$10
2024-12-16
Reason
Goldman Sachs
Jamie Perse
Price Target
$10
2024-12-16
Upgrades
Hold
to
Strong Buy
Reason
Barclays
Stephanie Davis
Sell
Maintains
$6 → $7
2024-11-11
Reason
Barclays
Stephanie Davis
Price Target
$6 → $7
2024-11-11
Maintains
Sell
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for LifeStance Health Group Inc (LFST.O) is -106.43, compared to its 5-year average forward P/E of -32.28. For a more detailed relative valuation and DCF analysis to assess LifeStance Health Group Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
-32.28
Current PE
-106.43
Overvalued PE
-3.04
Undervalued PE
-61.53
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued
5Y Average EV/EBITDA
47.86
Current EV/EBITDA
13.99
Overvalued EV/EBITDA
81.40
Undervalued EV/EBITDA
14.31
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
3.10
Current PS
1.14
Overvalued PS
5.39
Undervalued PS
0.80
Financials
Annual
Quarterly
FY2025Q1
YoY :
+10.83%
332.97M
Total Revenue
FY2025Q1
YoY :
-113.22%
2.04M
Operating Profit
FY2025Q1
YoY :
-103.36%
709.00K
Net Income after Tax
FY2025Q1
YoY :
-100.00%
0.00
EPS - Diluted
FY2025Q1
YoY :
-61.92%
-10.26M
Free Cash Flow
FY2025Q1
YoY :
0.00%
100.00
Gross Profit Margin - %
FY2025Q1
YoY :
-228.09%
7.98
FCF Margin - %
FY2025Q1
YoY :
-102.99%
0.21
Net Margin - %
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 318.77% over the last month.
Sold
0-3
Months
144.3K
USD
2
3-6
Months
428.8K
USD
5
6-9
Months
644.0K
USD
2
0-12
Months
33.1K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
932.2K
Volume
1
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areSelling! The selling amount has increased 318.77% over the last month.
Sold
0-3
Months
144.3K
USD
2
3-6
Months
428.8K
USD
5
6-9
Months
644.0K
USD
2
0-12
Months
33.1K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
LFST News & Events
Events Timeline
2025-05-14 (ET)
2025-05-14
09:01:42
LifeStance appoints Vaughn Paunovich as CTO

2025-05-07 (ET)
2025-05-07
06:07:23
LifeStance still sees 2025 revenue $1.40B-$1.44B, consensus $1.42B

2025-05-07
06:05:54
LifeStance reports Q1 EPS 0c vs. (6c) last year

Sign Up For More Events
Sign Up For More Events
News
4.0
06-27NASDAQ.COMLifeStance Health (LFST) Upgraded to Strong Buy: What Does It Mean for the Stock?
4.0
05-28TipRanks3 Best Stocks to Buy Now, 5/28/2025, According to Top Analysts
6.0
05-27TipRanks“50% Upside” Possible for Lifestance Health Stock (NASDAQ:LFST), Shares Surge
Sign Up For More News
People Also Watch

AMED
Amedisys Inc
97.940
USD
+0.11%

PENN
PENN Entertainment Inc
19.230
USD
+5.60%

RNG
RingCentral Inc
26.690
USD
-2.34%

CWK
Cushman & Wakefield PLC
11.880
USD
+1.80%

USAC
USA Compression Partners LP
24.560
USD
-1.09%

GRND
Grindr Inc
18.290
USD
-4.49%

ALRM
Alarm.com Holdings Inc
55.650
USD
+0.65%

CAAP
Corporacion America Airports SA
20.330
USD
+0.64%

UEC
Uranium Energy Corp
8.910
USD
+1.60%

BHF
Brighthouse Financial Inc
50.210
USD
+1.29%
FAQ

What is LifeStance Health Group Inc (LFST) stock price today?
The current price of LFST is 4.14 USD — it has increased 0 % in the last trading day.

What is LifeStance Health Group Inc (LFST)'s business?

What is the price predicton of LFST Stock?

What is LifeStance Health Group Inc (LFST)'s revenue for the last quarter?

What is LifeStance Health Group Inc (LFST)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for LifeStance Health Group Inc (LFST)'s fundamentals?

How many employees does LifeStance Health Group Inc (LFST). have?
